Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet licensed by the MHRA or EMA in the UK
Collagen peptides, in association with vitamin C, sodium hyaluronate, manganese and copper, as part of the rehabilitation project in the treatment of chronic low back pain
Material & Safety
Stress, mental ill-health and functional somatic syndromes in incident and chronic sleep disturbance in a general adult population
Understanding these mechanisms is essential when considering long-term treatment outcomes, as the body's response to these medications can evolve over time through various physiological adaptations
Focus on compound movements that recruit multiple muscle groups and allow you to handle meaningful weight